NVZMY vs. VERX
NVZMY (Novozymes AS) and VERX (Vertex, Inc.) are both stocks. NVZMY operates in Specialty Chemicals (Basic Materials), while VERX operates in Software - Application (Technology). Over the past 5 years, NVZMY returned -3.38%/yr vs -6.85%/yr for VERX. At a 0.14 correlation, their price movements are largely independent.
Performance
NVZMY vs. VERX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NVZMY achieves a -9.56% return, which is significantly higher than VERX's -35.95% return.
NVZMY
- 1D
- -1.49%
- 1M
- -8.79%
- YTD
- -9.56%
- 6M
- -5.39%
- 1Y
- -17.70%
- 3Y*
- 6.85%
- 5Y*
- -3.38%
- 10Y*
- 3.16%
VERX
- 1D
- -7.65%
- 1M
- -4.12%
- YTD
- -35.95%
- 6M
- -35.34%
- 1Y
- -68.70%
- 3Y*
- -16.19%
- 5Y*
- -6.85%
- 10Y*
- —
NVZMY vs. VERX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
NVZMY Novozymes AS | -9.56% | 14.29% | 3.97% | 12.42% | -38.46% | 46.93% | -5.38% |
VERX Vertex, Inc. | -35.95% | -62.57% | 98.03% | 85.67% | -8.57% | -54.46% | 45.63% |
Correlation
The correlation between NVZMY and VERX is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.17 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.10 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.15 |
Correlation (All Time) Calculated using the full available price history since Jul 30, 2020 | 0.14 |
Fundamentals
NVZMY:
$1.28
VERX:
-$0.05
NVZMY:
2.41
VERX:
2.07
NVZMY:
$11.07B
VERX:
$768.03M
NVZMY:
$5.79B
VERX:
$486.52M
NVZMY:
$3.39B
VERX:
$51.70M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NVZMY vs. VERX — Risk / Return Rank
NVZMY
VERX
NVZMY vs. VERX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Novozymes AS (NVZMY) and Vertex, Inc. (VERX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| NVZMY | VERX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.72 | -1.18 | +0.45 |
Sortino ratioReturn per unit of downside risk | -0.95 | -2.20 | +1.26 |
Omega ratioGain probability vs. loss probability | 0.89 | 0.73 | +0.16 |
Calmar ratioReturn relative to maximum drawdown | -0.60 | -0.93 | +0.33 |
Martin ratioReturn relative to average drawdown | -1.04 | -1.32 | +0.28 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| NVZMY | VERX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.72 | -1.18 | +0.45 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.12 | -0.13 | 0.00 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.12 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.08 | -0.18 | +0.10 |
Drawdowns
NVZMY vs. VERX - Drawdown Comparison
The maximum NVZMY drawdown since its inception was -86.29%, which is greater than VERX's maximum drawdown of -81.68%. Use the drawdown chart below to compare losses from any high point for NVZMY and VERX.
Loading charts...
Drawdown Indicators
| NVZMY | VERX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -86.29% | -81.68% | -4.61% |
Max Drawdown (1Y)Largest decline over 1 year | -29.64% | -74.21% | +44.57% |
Max Drawdown (3Y)Largest decline over 3 years | -29.64% | -81.68% | +52.04% |
Max Drawdown (5Y)Largest decline over 5 years | -51.86% | -81.68% | +29.82% |
Max Drawdown (10Y)Largest decline over 10 years | -51.86% | — | — |
Current DrawdownCurrent decline from peak | -61.08% | -78.30% | +17.22% |
Average DrawdownAverage peak-to-trough decline | -57.41% | -42.24% | -15.17% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 17.02% | 51.97% | -34.95% |
Volatility
NVZMY vs. VERX - Volatility Comparison
The current volatility for Novozymes AS (NVZMY) is 7.10%, while Vertex, Inc. (VERX) has a volatility of 27.71%. This indicates that NVZMY experiences smaller price fluctuations and is considered to be less risky than VERX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NVZMY | VERX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.10% | 27.71% | -20.61% |
Volatility (6M)Calculated over the trailing 6-month period | 16.86% | 47.52% | -30.66% |
Volatility (1Y)Calculated over the trailing 1-year period | 24.67% | 58.61% | -33.94% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 27.71% | 54.49% | -26.78% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 27.13% | 55.71% | -28.58% |
Dividends
NVZMY vs. VERX - Dividend Comparison
NVZMY's dividend yield for the trailing twelve months is around 1.79%, while VERX has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NVZMY Novozymes AS | 1.79% | 1.51% | 1.03% | 2.68% | 1.68% | 0.69% | 0.91% | 1.03% | 1.10% | 1.64% | 0.95% | 0.60% |
VERX Vertex, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
NVZMY vs. VERX - Financials Comparison
This section allows you to compare key financial metrics between Novozymes AS and Vertex, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
NVZMY vs. VERX - Profitability Comparison
NVZMY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Novozymes AS reported a gross profit of 644.63M and revenue of 1.14B. Therefore, the gross margin over that period was 56.7%.
VERX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Vertex, Inc. reported a gross profit of 124.87M and revenue of 196.65M. Therefore, the gross margin over that period was 63.5%.
NVZMY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Novozymes AS reported an operating income of 272.81M and revenue of 1.14B, resulting in an operating margin of 24.0%.
VERX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Vertex, Inc. reported an operating income of -10.61M and revenue of 196.65M, resulting in an operating margin of -5.4%.
NVZMY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Novozymes AS reported a net income of 202.37M and revenue of 1.14B, resulting in a net margin of 17.8%.
VERX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Vertex, Inc. reported a net income of -2.51M and revenue of 196.65M, resulting in a net margin of -1.3%.
Frequently Asked Questions
NVZMY and VERX have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
VERX has higher volatility (27.71%) compared to NVZMY (7.10%). In terms of maximum drawdown, NVZMY dropped -86.29% vs VERX's -81.68%.
NVZMY currently has the higher Sharpe Ratio (-0.72 vs -1.18), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NVZMY and VERX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer